Vascular Solutions, Inc. (VASC) Receives Average Recommendation of “Hold” from Brokerages

Vascular Solutions, Inc. (NASDAQ:VASC) has received an average recommendation of “Hold” from the seven ratings firms that are presently covering the stock. Six equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $47.00.

A number of research firms have recently commented on VASC. Feltl & Co. cut shares of Vascular Solutions from a “buy” rating to a “hold” rating in a report on Friday, December 2nd. Zacks Investment Research cut shares of Vascular Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, December 28th. Piper Jaffray Companies cut shares of Vascular Solutions from an “overweight” rating to a “neutral” rating in a report on Monday, December 5th. Needham & Company LLC cut shares of Vascular Solutions from a “buy” rating to a “hold” rating in a report on Friday, December 2nd. Finally, Canaccord Genuity cut shares of Vascular Solutions from a “buy” rating to a “hold” rating in a report on Monday, December 5th.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Capstone Investment Advisors LLC bought a new position in Vascular Solutions during the fourth quarter worth approximately $214,000. Municipal Employees Retirement System of Michigan boosted its position in Vascular Solutions by 1.6% in the third quarter. Municipal Employees Retirement System of Michigan now owns 3,850 shares of the medical device company’s stock worth $186,000 after buying an additional 60 shares during the last quarter. Campbell Newman Asset Management Inc. bought a new position in Vascular Solutions during the third quarter worth approximately $203,000. First Mercantile Trust Co. boosted its position in Vascular Solutions by 129.4% in the third quarter. First Mercantile Trust Co. now owns 4,242 shares of the medical device company’s stock worth $205,000 after buying an additional 2,393 shares during the last quarter. Finally, TD Asset Management Inc. bought a new position in Vascular Solutions during the third quarter worth approximately $206,000. Hedge funds and other institutional investors own 80.18% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Mideast Time and is the property of of Mideast Time. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.mideasttime.com/vascular-solutions-inc-vasc-receives-average-recommendation-of-hold-from-brokerages/1589538.html.

Shares of Vascular Solutions (NASDAQ:VASC) remained flat at $56.00 on Monday. The stock has a 50 day moving average price of $55.89 and a 200-day moving average price of $51.22. Vascular Solutions has a 52-week low of $25.06 and a 52-week high of $57.15.

Vascular Solutions Company Profile

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

5 Day Chart for NASDAQ:VASC

Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.